17β-estradiol promotes striatal medium size spiny neuronal maturation in vitro

Neuroendocrinology

Volumn 79, Issue 5, 2004, Pages 259-267

  Stroppolo, Antonella ^a   Tian, Chai ^a   Guinea, Barbara ^a   Olm, Vicki ^a   Sheffield, Roxanne ^a   Sommer, John ^a   Ehrlich, Michelle E ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brain derived neurotrophic factor; Catecholamines; DARPP 32; Gonadal steroid antagonists; Gonadal steroid receptors; Gonadal steroids; Selective estrogen receptor modulators; Spiny neurons; Striatum; Tamoxifen

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; PHOSPHOPROTEIN DARPP 32; TAMOXIFEN; DRUG DERIVATIVE; ESTROGEN RECEPTOR; NERVE PROTEIN; PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL CULTURE; CELL MATURATION; CELL SIZE; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; WESTERN BLOTTING; ANIMAL; CAUDATE NUCLEUS; CLASSIFICATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PHYSIOLOGY; SEX DIFFERENCE;

ANIMALS; CAUDATE NUCLEUS; CELLS, CULTURED; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR BETA; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; RECEPTORS, ESTROGEN; SEX FACTORS; TAMOXIFEN;

EID: 3242780258     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079320     Document Type: Article

References (57)

1. Andersen AL, Rutstein M, Benzo JM, Hostetter JC, Teicher MH: Sex differences in dopamine receptor overproduction and elimination. Neuroreport 1997;8:1495-1498.
2. Andersen SL, Thompson AP, Krenzel E, Teicher MH: Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology 2002;27:683-691.
3. Floerke-Nashner LR, Burlingame LA, Berger-Sweeney J: Sex differences in neurogenesis in mouse striatum. Soc Neurosci Abstr 2000;30: 224.9.
4. Kurlan R: The pathogenesis of Tourette's syndrome: A possible role for hormonal and excitatory neurotransmitter influences in brain development. Arch Neurol 1992;49:874-876.
5. Kompoliti K: Estrogen and movement disorders. Clin Neuropharmacol 1999;22:318-326.
6. Tsang KL, Ho SL, Lo SK: Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000;54:2292-2298.
7. Becker JB, Molenda H, Hummer DL: Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann NY Acad Sci 2001;937:172-187.
8. Euvrard C, Oberlander C, Boissier JR: Antidopaminergic effects of estrogens at the striatal level. J Pharmacol Exp Ther 1980;214:179-185.
9. Becker JB: Direct effect of 17β-estradiol on striatum: Sex differences in dopamine release. Synapse 1990;5:157-164.
10. Becker JB: Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999;64:803-812.
11. Mermelstein PG, Becker JB, Surmeier DJ: Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 1996;16:595-604.
12. Tansey EM, Arbuthnott GW, Fink G, Whale D: Oestradiol-17β increases the firing rate of antidromically identified neurons of the rat neostriatum. Neuroendocrinology 1983;37: 106-110.
13. Arnauld E, Dufy B, Pestre M, Vincent JD: Effects of estrogens on the response of caudate neurons to microiontophoretically applied dopamine. Neurosci Lett 1981;21:325-331.
14. Maus M, Bertrand P, Drouva S, Rasolonjanahary R, Kordon C, Glowinski J, Premont J, Enjalbert A: Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17β-estradiol in cultured striatal neurons and anterior pituitary cells. J Neurochem 1989;52: 410-418.
15. Lee SH, Mouradian MM: Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 1999;156:151-157.
16. Zhou Y, Dorsa DM: Estrogen rapidly induces c-jun immunoreactivity in rat striatum. Horm Behav 1994;28:376-382.
17. Hruska RE, Ludmer LM, Pitman KT, De Ryck M, Silbergeld EK: Effects of estrogen on striatal dopamine receptor function in male and female rats. Pharmacol Biochem Behav 1982;16: 285-291.
18. Hruska RE, Nowak MW: Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum. Brain Res 1988;442:349-350.
19. Ivkovic S, Ehrlich ME: Expression of the DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 1999;19:5409-5419.
20. Greengard P: The neurobiology of slow synaptic transmission. Science 2001;294:1024-1030.
21. Quimet CC, Langley-Gullion KC, Greengard P: Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res 1998;808:8-12.
22. Nakao N, Brundin P, Funa K, Lindvall O, Odin P: Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Dev Brain Res 1995;90:92-101.
23. Ivkovic S, Polonskaia O, Farinas I, Ehrlich ME: Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: Studies in vivo and in vitro. Neuroscience 1997;79:509-516.
24. Ehrlich ME, Rosen NL, Kurihara T, Shalaby IA, Greengard P: DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra. Dev Brain Res 1990;54:257-263.
25. Brewer GJ: Serum-free B27/Neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 1995;42:674-683.
26. Iacovitti L, Stull ND, Mishizen A: Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture. Brain Res 1999;816:276-285.
27. Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serumfree medium combination. J Neurosci Res 1993;35:567-576.
28. Jones PS, Parrott E, White INH: Activation of transcription by estrogen receptor α and β cell type- and promoter-dependent. J Biol Chem 1999;274:32008-32014.
29. Wade CB, Robinson S, Shapiro RA, Dorsa DM: Estrogen receptor (ER)α and ERβ exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 2001;142: 2336-2342.
30. Foster GA, Schultzberg M, Kokfelt T, Goldstein M, Hemmings HC Jr, Ouimet CC, Walaas SI, Greengard P: Ontogenity of the dopamine and cyclic adenosine-3),5)-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system. Int J Dev Neurosci 1988;6:367-386.
31. Gustafson E, Ehrlich ME, Trivedi P, Greengard P: Developmental regulation of phosphoprotein gene expression in the caudate putamen of rat: An in situ hybridization study. Neuroscience 1992;51:65-75.
32. Graybiel A: Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:244-254.
33. Auger AP, Tetel MJ, McCarthy MM: Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc Natl Acad Sci USA 2000; 97:7551-7555.
34. McDonnell DP, Norris JD: Connections and regulation of the human estrogen receptor. Science 2002;296:1642-1644.
35. Kuppers E, Beyer C: Expression of aromatase in the embryonic and postnatal mouse striatum. Mol Brain Res 1998;63:184-188.
36. Foster WG, Chan S, Platt L, Hughes CL Jr: Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 2002;129:199-205.
37. Toran-Allerand CD, Miranda RC, Hochberg RB, MacLusky NJ: Cellular variation in estrogen receptor mRNA translation in the developing brain. Brain Res 1992;576:25-41.
38. Kuppers E, Beyer C: Expression of estrogen receptor-α and -β mRNA in the developing and adult mouse striatum. Neurosci Lett 1999;276: 95-98.
39. Shughrue P, Scrimo P, Lane M, Askew R, Merchenthaler I: The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse. Endocrinology 1997;138:5649-5652.
40. Shughrue PJ, Merchenthaler I: Distribution of estrogen receptor β immunoreactivity in the rat central nervous system. J Comp Neurol 2001; 436:64-81.
41. Mitra WM, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE: Immunolocalization of estrogen receptor β in the mouse brain: Comparison with estrogen receptor α. Endocrinology 2003;144:2055-2067.
42. Pfaff D, Keiner M: Atlas of estradiol-concentrating cells in the central nervous system of the rat. J Comp Neurol 1973;151:121-158.
43. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S: Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: Anatomical evidence of distinct roles of each subtype. J Neurobiol 1998;36:357-378.
44. Shughrue PJ, Stumpf WE, MacLusky NJ, Zielinski JE, Hochberg RB: Developmental changes in estrogen receptors in mouse cerebral cortex between birth and postweaning: Studied by autoradiography with 11β-methoxy- 16α-[125I]iodoestradiol. Endocrinology 1990;126: 1112-1124.
45. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ES Jr, Nethrapalli IS, Tinnikov AA: ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 2002;22:8391-8401.
46. Sato K, Matsui N, Ohno Y, Nakazawa K: Effects of 17β-estradiol and xenoestrogens on the neuronal survival in an organotypic hippocampal culture. Neuroendocrinology 2002;76: 223-234.
47. Webb P, Lopez GN, Uht RM, Kushner PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995;9:443-456.
48. Paech K, Webb P, Kuiper GGJM, Nilsson G, Gustafsson JA, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997;277: 1508-1510.
49. Shapiro RA, Xu C, Dorsa DM: Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor α and β. Endocrinology 2000;141:4056-4064.
50. Becker JB: Oestrogen effects on dopaminergic function in striatum; in Neuronal and Cognitive Effects of Oestrogens. Novartis Found Symp 230. Chichester, Wiley, 2000, pp 134-151.
51. Xiao L, Jackson LR, Becker JB: The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: Pharmacological and behavioural evidence. Neuroendocrinology 2003;77:239-245.
52. Beyer C, Karolczak M: Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J Neurosci Res 2000;59:107-116.
53. Lee D, Wang L, Dong P, Tran T, Copolov D, Lim AT: Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen. Mol Psychiatry 2001;6: 112-117.
54. Stroppolo A, Guinea B, Tian C, Sommer J, Ehrlich ME: Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factorinduced DARPP-32 expression in medium size spiny neurons in vitro. J Neurochem 2001;79: 1027-1032.
55. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK: Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-541.
56. Wang L, Andersson S, Warner M, Gustafsson JA: Morphological abnormalities in the brains of estrogen receptor β knockout mice. Proc Natl Acad Sci USA 2001;98:2792-2796.
57. Dorling AA, Todman MG, Korach KS, Herbison AE: Critical role for estrogen receptor alpha in negative feedback regulation of gonadotropin-releasing hormone mRNA expression in the female mouse. Neuroendocrinology 2003; 78:204-209.